Jennewein Biotechnologie Overview
- Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
100
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
1
Jennewein Biotechnologie General Information
Description
Operator of an industrial biotechnology company specializing in human milk oligosaccharides (HMOs) and rare monosaccharides products. The company manufactures an extensive portfolio of innovative HMO products, such as 2' fucosyllactose, 3'-fucosyllactose, Lacto-N-neotetraose, and Lacto-N-tetraose and these rare sugars are used in the food industry particularly infant milk formulas, the pharmaceutical industry and the cosmetic industry.
Contact Information
Website
www.jennewein-biotech.de
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
- Maarweg 32
- 53619 Rheinbreitbach
- Germany
Jennewein Biotechnologie Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jennewein Biotechnologie Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of an industrial biotechnology company specializing in human milk oligosaccharides (HMOs) and rare monosacchari
Biotechnology
Rheinbreitbach, Germany
100
As of 2020
000.00
0000
0000-00-00
000000&0
000.00
000000
reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
0000000000000
Horsholm, Denmark
000
As of 0000
000.00
0000
0000-00-00
000000&0
000.00
Add Comparison
Jennewein Biotechnologie Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 000000 | Formerly PE-Backed | Horsholm, Denmark | 000 | 000.00 | 000000&0 | 000.00 |
Jennewein Biotechnologie Patents
Jennewein Biotechnologie Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018373415-A1 | Process for the purification of a sialic acid from a fermentation broth | Pending | 21-Nov-2017 | 000000000 | |
| AU-2018373610-A1 | Process for the purification of l-fucose from a fermentation broth | Pending | 21-Nov-2017 | 000000000 | |
| EP-3714059-A1 | Process for the purification of l-fucose from a fermentation broth | Pending | 21-Nov-2017 | 000000000 | |
| EP-3714060-A1 | Process for the purification of a sialic acid from a fermentation broth | Active | 21-Nov-2017 | 000000000 | |
| EP-3486326-A1 | Method for the purification of n-acetylneuraminic acid from a fermentation broth | Pending | 21-Nov-2017 | C12P19/02 | 00 |
Jennewein Biotechnologie Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Jennewein Biotechnologie Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 08-Oct-2018 | 000000000 | Buildings and Property | 0000000 0 |